Market Update

India Movers: Axis Bank, IDFC, Mukand, Mayur Uniquoters

Mukesh Buch
20 Mar, 2014
New York City

Axis Bank said UTI will lower its stake and sell 4.22 crore shares. IDFC plans to raise $122.94 million for a debt fund. Mukand surged after promoters increased their stake. Mayur Uniquoters board approved to raise $11.4 million.

Australian Indexes Drop 1.2%

Marcus Jacob
20 Mar, 2014
New York City

Australian markets turned lower and the Aussie dollar eased after the prospects of interest rate increase in the U.S. rose after the Federal Reserve trimmed its bond purchase program. Myer Holdings reported interim earnings decline of 8%.

Nikkei Falls on U.S. Rate Worries, Toyota Probe Costs Rise to $3 B

Hiruki Nakamura
20 Mar, 2014
New York City

Nikkei index in Tokyo dropped 1.6% on the prospect of rising interest rate in the U.S. Toyota agreed to settle U.S. Department of Justice probe for $1.25 billion and the total cost of sudden acceleration in vehicles inquiries increased to $3 billion.

Europe Earnings: SKF, Cello Group, Lloyds, Munich Re, Next

Nigel Thomas
20 Mar, 2014
New York City

SKF agreed to pay

Endocyte, Nortek, Tiffany Jump; AAR, Nike, Symantec Tumble

Mukesh Buch
21 Mar, 2014
New York City

AAR net plunged 23% on sales decline of 9%. Darden Restaurants profit dropped 18%. Endocyte surged after European Medicines Agency issued a positive opinion on cancer drug. Nike net tumbled 21% but revenue climbed. Tiffany net swung to loss.

IHS Rises; Cato, Scholastic Tumble

Mukesh Buch
20 Mar, 2014
New York City

Cato tumbled after net and sales dropped and lowered its outlook. ConAgra surged 95% and sales climbed 15%. IHS climbed 31% as revenue surged 37%. Lennar profit jumped 36%. Scholastic net tumbled 40%.

Europe Earnings: Bouygues, Balfour Beatty, Havas, Intu Properties, Investec

Nigel Thomas
21 Mar, 2014
New York City

Bouygues revised its SFR bid to

Australian Index Extend Gains, Metcash Plunged 10%

Marcus Jacob
21 Mar, 2014
New York City

Australian market indexes advanced in heavy trading and the Aussie dollar traded above 90 U.S. cents. Four largest Australian banks are leading the global capital raising plan of $7.2 billion to fund Roy Hill iron ore mining project. Metcash plunged 10%. Cochlear gained 3%.

India Movers: Canara Bank, Claris Lifesciences, IDBI, Il&FS, Jain Irrigation

Mukesh Buch
21 Mar, 2014
New York City

Canara Bank plans to raise Rs 1,000 crore through a bond offering. Claris Lifesciences set up a stock buyback program of Rs 231 crore. IDBI Bank will sell its entire 19% stake in SHCI. Jain Irrigation allotted 7.5 million shares at Rs 86.30 per share.

Liberty Media and Ulta Salon jumped 7%; Aeropostale, Hibbett Sports Decline

Mukesh Buch
14 Mar, 2014
New York City

Anacor Pharma net swung to profit after sales surged. Aeropostale tumbled after net loss widened. Buckle profit and sales dropped. Hibbett Sports net plunged 13%. Ulta Salon net climbed 9%. Wix.com agreed to acquire mobile application builder Appixia.

Europe Earnings: Ocado, Pandora, SThree, UBS, Vodafone

Nigel Thomas
14 Mar, 2014
New York City

Ocado reported sales increase of 23% to

India Movers: AstraZeneca, Airtel, BF Utilities, Hero, KEC Intl, Mphasis

Mukesh Buch
14 Mar, 2014
New York City

AstraZeneca Pharma is scheduled to meet tomorrow to decide delisting. Bharti Airtel completed a bond offering of $400 million. BF Utilities plunged after promoters sold their stakes by 0.34%. KEC Intl won order worth Rs 1,200 crore. Mphasis net declined 5%.

Dex Media, Williams-Sonoma Rise; Dollar General Falls

Mukesh Buch
13 Mar, 2014
New York City

Dollar General net rose 2% and sales climbed 7%. Dex Media net loss widened and repaid $541 million of bank debt in the quarter. Genesco profit climbed 9%. Stein Mart net plunged 45% and comparable sales jumped 3.1%. Williams-Sonoma net soared 9%.

Europe Earnings: Bouygues, BMW, Deutsche Lufthansa, Wm Morrison

Nigel Thomas
13 Mar, 2014
New York City

Bouygues raised its bid for Vivendi''s telecom unit SFR to

India Movers: Infosys, Jubilant Life Sciences, L&T, Sun Pharma, Tata

Mukesh Buch
13 Mar, 2014
New York City

Infosys tumbled after the software solutions provider lowered its fiscal outlook. Jubilant Life Sciences surged after the supplements maker lifted prices of vitamin B3 by 18%. L&T secured an order worth Rs 3,655 crore in Qatar.